EnzymeRxParamus, New Jersey, United StatesEnzymeRx is a biotechnology company developing uricase-PEG 20 for the treatment of resistant and refractory gout and related indications. RESEARCH STARTUP VISIT WEBSITE
CellPoint DiagnosticsLa Jolla, California, United StatesCellPoint Diagnostics is an early stage company developing diagnostic, monitoring, and molecular analytical tools for cancer. RESEARCH STARTUP VISIT WEBSITE
Cabrellis PharmaceuticalsSan Diego, California, United StatesCabrellis Pharmaceuticals Corporation develops therapies for the treatment of cancer. RESEARCH STARTUP VISIT WEBSITE
Vivendy TherapeuticsBasel, Basel-Stadt, SwitzerlandVivendy Therapeutics is engaged in the development of enzyme replacement therapy. RESEARCH STARTUP VISIT WEBSITE
